Anti-GP153/ GPR153/ PGR1 monoclonal antibody

Anti-GP153/ GPR153/ PGR1 antibody for FACS & in-vivo assay

Target products collectionGo to GPR153/GPR153 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0516-Ab-1/ GM-Tg-hg-MP0516-Ab-2Anti-Human GPR153 monoclonal antibodyHuman
GM-Tg-rg-MP0516-Ab-1/ GM-Tg-rg-MP0516-Ab-2Anti-Rat GPR153 monoclonal antibodyRat
GM-Tg-mg-MP0516-Ab-1/ GM-Tg-mg-MP0516-Ab-2Anti-Mouse GPR153 monoclonal antibodyMouse
GM-Tg-cynog-MP0516-Ab-1/ GM-Tg-cynog-MP0516-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR153 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0516-Ab-1/ GM-Tg-felg-MP0516-Ab-2Anti-Feline GPR153 monoclonal antibodyFeline
GM-Tg-cang-MP0516-Ab-1/ GM-Tg-cang-MP0516-Ab-2Anti-Canine GPR153 monoclonal antibodyCanine
GM-Tg-bovg-MP0516-Ab-1/ GM-Tg-bovg-MP0516-Ab-2Anti-Bovine GPR153 monoclonal antibodyBovine
GM-Tg-equg-MP0516-Ab-1/ GM-Tg-equg-MP0516-Ab-2Anti-Equine GPR153 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0516-Ab-1/ GM-Tg-hg-MP0516-Ab-2; GM-Tg-rg-MP0516-Ab-1/ GM-Tg-rg-MP0516-Ab-2;
GM-Tg-mg-MP0516-Ab-1/ GM-Tg-mg-MP0516-Ab-2; GM-Tg-cynog-MP0516-Ab-1/ GM-Tg-cynog-MP0516-Ab-2;
GM-Tg-felg-MP0516-Ab-1/ GM-Tg-felg-MP0516-Ab-2; GM-Tg-cang-MP0516-Ab-1/ GM-Tg-cang-MP0516-Ab-2;
GM-Tg-bovg-MP0516-Ab-1/ GM-Tg-bovg-MP0516-Ab-2; GM-Tg-equg-MP0516-Ab-1/ GM-Tg-equg-MP0516-Ab-2
Products NameAnti-GPR153 monoclonal antibody
Formatmab
Target NameGPR153
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPR153 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GP153/ GPR153/ PGR1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0516
    Target NameGPR153
    Gene ID387509,100129,619550,703169,489630,101093874,518906,100059643
    Gene Symbol and Synonyms1110065N12Rik,GPR153,PGR1
    Uniprot AccessionQ6NV75
    Uniprot Entry NameGP153_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000158292
    Target ClassificationGPCR

    The target: GPR153, gene name: GPR153, also named as PGR1. This gene encodes an integral membrane protein that belongs to the Class A rhodopsin superfamily of G protein coupled receptors. The encoded protein is expressed primarily in the central nervous system. A knockdown of the orthologous gene in rat is associated with a significant reduction in food intake and impaired decision making ability. Mutations in this gene are associated with schizophrenia, autism, and other neuropsychiatric disorders. The expression of this gene is activated by the glioma-associated oncogene homolog 1 transcription factor which, in turn, is activated by sonic hedgehog in normal and tumorigenic cells. [provided by RefSeq, Feb 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.